T +49 69 29994 1228
Robert Nachama advises banks and other financial institutions, private equity investors and corporates in connection with public and private debt and equity transactions, including high yield debt offerings and as well as in connection with loan/bond structures, acquisition finance and leveraged finance.
Advising Swiss Zur Rose Group AG, Europe's largest online pharmacy and one of the leading medical wholesalers in Switzerland, on its CHF200 million rights offering, which was completed in connection with the acquisition of the online pharmacy competitor medpex.
Advising Pfleiderer AG on a successful German insolvency law restructuring (2012-2013)*
Advising a syndicate of banks on a loan and high yield bond combination for Schmolz + Bickenbach AG (2012)*
Advising Techem GmbH on a loan and high yield note (2012)*
Advising IVG Immobilien AG on a capital increase with pre-emptive rights and US private placement (2011)*
Advising UBS, Berenberg Bank and equinet Bank on the IPO of RIB Software AG with US private placement (2011)*
Advising Barclays Bank PLC on a capital increase of Aurubis AG without pre-emptive rights and with US private placement (2011)*
Advising Morgan Stanley and Raiffeisen Centrobank on a capital increase of VERBUND AG with pre-emptive rights and US private placement (2010)*
Advising Heidelberger Druckmaschinen AG on a capital increase with pre-emptive rights and US private placement (2010)*
Advising Volkswagen AG on a capital increase with pre-emptive rights and pre-placement as well as US private placement (2010)*
* Matters prior to working for White & Case.